U S Physical Therapy Inc: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Aug 6, 2015 and accepted by EDGAR at Aug 6, 2015, 10:47 ET.
Management's discussion and analysis
As filed, 31,154 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following is a discussion of our historical consolidated financial condition and results of operations, and should be read in conjunction with (i) our historical consolidated financial statements and accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q; (ii) our Annual Report on Form 10-K for the year ended December 31, 2014 filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2015; and (iii) our management’s discussion and analysis of financial condition and results of operations included in our 2014 Form 10-K. This discussion includes forward-looking statements that are subject to risk and uncertainties. This discussion includes forward-looking statements that are subject to risk and uncertainties. Actual results may differ substantially from the statements we make in this section due to a number of factors that are discussed in “Forward-Looking Statements” herein and “Part I – Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2014
References to “we,” “us,” “our” and the “Company” shall mean U.S. Physical Therapy, Inc. and its subsidiaries.
EXECUTIVE SUMMARY
Our Business
We operate outpatient physical therapy clinics that provide preventive and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. As of June 30, 2015, we operated 501 clinics in 42 states.
We also manage physical therapy facilities for third parties, primarily physicians, with 19 third-party facilities under management as of June 30, 2015.
During the six months of 2015 and the year ended 2014, we acquired the following clinic groups:
| Acquisition | Date 2015 | % Interest Acquired | Number of Clinics |
|---|---|---|---|
| January 2015 Acquisition | January 31 | 60% | 9 |
| April 2015 Acquisition | April 30 | 70% | 3 |
| June 2015 Acquisition | June 30 | 70% | 4 |
| 2014 | |||
| April 2014 Acquisition | April 30 | 70% | 13 |
| August 2014 Acquisition | August 1 | 100% | 3 |
On June 30, 2015, we acquired a 70% interest in a four-clinic physical therapy practice. The purchase price was $3.6 million in cash and $0.7 million in seller notes that are payable plus accrued interest, in June 2018. On April 30, 2015, we acquired a 70% interest in a three-clinic physical therapy practice. The purchase price was $4.75 million in cash and $0.15 million in a seller note that is payable in two principal installments of $75,000 each, plus accrued interest, in April 2016 and 2017. On January 31, 2015, we acquired a 60% interest in a nine-clinic physical therapy practice. The purchase price for the 60% interest was $6.7 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in January 2016 and 2017.
On April 30, 2014, we acquired a 70% interest in a 13-clinic physical therapy practice. The purchase price for the 70% interest was $10.6 million in cash and $0.4 million in a seller note that is payable in two principal installments totaling $200,000 each, plus accrued interest, in April 2015 and 2016. On August 1, 2014, we acquired a 100% interest in a 3-clinic physical therapy practice. The purchase price for the 100% interest was $1.0 million in cash. In addition, during 2014, the Company acquired three individual clinic practices for an aggregate of $595,000 in cash.
The results of operations of the acquired clinics have been included in our consolidated financial statements since the date of their acquisition.
Selected Operating and Financial Data
The following table presents selected operating and financial data that we believe are key indicators of our operating performance.
| For the Three Months Ended June 30, 2015 | 2014 | For the Six Months Ended June 30, 2015 | 2014 | |
|---|---|---|---|---|
| Number of clinics, at the end of period | 501 | 486 | 501 | 486 |
| Working days | 64 | 64 | 127 | 127 |
| Average visits per day per clinic | 24.4 | 23.3 | 23.6 | 22.4 |
| Total patient visits | 776,867 | 718,767 | 1,489,722 | 1,362,636 |
| Net patient revenue per visit | $104.85 | $106.39 | $105.56 | $106.31 |
RESULTS OF OPERATIONS
Three Months Ended June 30, 2015 Compared to the Three Months Ended June 30, 2014
- Net revenues increased to $83.3 million for the three months ended June 30, 2015 (“2015 Second Quarter”) from $78.2 million for the three months ended June 30, 2014 (“2014 Second Quarter”) primarily due to an increase in visits of 58,100 from 718,800 for the 2014 Second Quarter to 776,900 for the 2015 Second Quarter offset by a decrease in the average net patient revenue per visit for the 2015 Second Quarter to $104.85 from $106.39 in the 2014 Second Quarter. This decrease in the average net patient revenue per visit was partially attributable to a small increase in the medicare/medicaid business and a small decrease in the workers compensation business.
- Net income attributable to our common shareholders prior to revaluation of redeemable non-controlling interests, net of tax, (“operating results”) for the 2015 Second Quarter was $6.3 million versus $6.4 million for the 2014 Second Quarter. Diluted earnings per share from operating results were $0.51 for the 2015 period and $0.53 for the comparable 2014 period. Total diluted shares were 12.4 million for the 2015 Second Quarter and 12.2 million for the 2014 Second Quarter.
Net Patient Revenues
- Net patient revenues increased to $81.5 million for the 2015 Second Quarter from $76.5 million for the 2014 Second Quarter, an increase of $5.0 million, or 6.5%, due to visits of 42,200 from clinics opened and acquired between July 1, 2014 and June 30, 2015 (“New Clinics”) and an increase in visits of 15,900 from clinics opened or acquired prior to July 1, 2014 (“Mature Clinics”) offset by a decrease in the net patient revenue per visit of $1.54.
- Net patient revenues related to New Clinics amounted to $4.4 million for the 2015 Second Quarter and net patient revenues for Mature Clinics increased by $0.6 million for the 2015 Second Quarter as compared to the 2014 Second Quarter.
Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers’ compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under these programs are based on predetermined rates and are generally less than the established billing rates.
Other Revenues
Other revenues increased $0.1 million in the 2015 Second Quarter to $1.8 million from $1.7 million in the 2014 Second Quarter.
Clinic Operating Costs
Clinic operating costs were $62.1 million, or 74.6% of net revenues, for the 2015 Second Quarter and $56.4 million, or 72.1% of net revenues, for the 2014 Second Quarter. The increase was primarily attributable to $3.9 million in operating costs of New Clinics and by an increase in operating costs of $1.8 million for Mature Clinics. Each component of clinic operating costs is discussed below:
Clinic Operating Costs—Salaries and Related Costs
Salaries and related costs increased to $44.4 million for the 2015 Second Quarter from $40.1 million for the 2014 Second Quarter, an increase of $4.3 million. Salaries and related costs for New Clinics amounted to $2.8 million for the 2015 Second Quarter. Salaries and related costs for Mature Clinics increased by $1.5 million for the 2015 Second Quarter as compared to the 2014 Second Quarter. Salaries and related costs as a percentage of net revenues were 53.3% for the 2015 Second Quarter and 51.3 % for the 2014 Second Quarter.
Clinic Operating Costs—Rent, Clinic Supplies, Contract Labor and Other
Rent, clinic supplies, contract labor and other were $16.7 million for the 2015 Second Quarter and $15.2 million for the 2014 Second Quarter. For New Clinics, rent, clinic supplies, contract labor and other amounted to $1.1 million for the 2015 Second Quarter. For Mature Clinics, rent, clinic supplies, contract labor and other increased by $0.4 million in the 2015 Second Quarter compared to the 2014 Second Quarter. Rent, clinic supplies, contract labor and other as a percentage of net revenues was 20.0% for the 2015 Second Quarter and 19.4% for the 2014 Second Quarter.
Clinic Operating Costs—Provision for Doubtful Accounts
The provision for doubtful accounts was $1.1 million for the 2015 Second Quarter and for the 2014 Second Quarter. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 1.3% for both periods.
Our allowance for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 4.4% at June 30, 2015, as compared to 4.8% at December 31, 2014. Our day’s sales outstanding were 38 days at June 30, 2015 and 39 days at December 31, 2014.
Corporate Office Costs
Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, accounting, professional, and recruiting fees, were $7.6 million for the 2015 Second Quarter and for the 2014 Second Quarter. As a percentage of net revenues, corporate office costs were 9.1% for the 2015 Second Quarter and 9.7% for the 2014 Second Quarter.
Interest Expense
Interest expense decreased to $245,000 in the 2015 Second Quarter compared to $332,000 in the 2014 Second Quarter. At June 30, 2015, $41.0 million was outstanding under our revolving credit agreement due to a lower average outstanding balance under our revolving credit agreement during to 2015 second quarter compared to the 2014 second quarter.
Provision for Income Taxes
The provision for income taxes was $4.2 million for the 2015 Second Quarter and $4.5 million for the 2014 Second Quarter. During the 2015 and 2014 Second Quarters, we accrued state and federal income taxes at an effective tax rate (provision for taxes divided by the difference between income before taxes and net income attributable to non-controlling interests) of 40.0% and 41.0%, respectively.
Non-controlling Interests
Net income attributable to non-controlling interests was $2.8 million for the 2015 Second Quarter and $3.0 million for the 2014 Second Quarter. As a percentage of operating income before corporate office costs, net income attributable to non-controlling interests was 13.3% for the 2015 Second Quarter and 13.7% for the 2014 Second Quarter.
Six Months Ended June 30, 2015 Compared to the Six Months Ended June 30, 2014
- Net revenues increased to $160.5 million for the six months ended June 30, 2015 (“2015 First Six Months”) from $148.0 million for the six months ended June 30, 2014 (“2014 First Six Months”) primarily due to an increase in visits of 127,100 from 1,362,600 for the 2014 First Six Months to 1,489,700 for the 2015 First Six Months offset by a decrease of $0.75 in the net patient revenue per visit.
- Operating results for the 2015 First Six Months was $10.5 million versus $10.7 million for the 2014 First Six Months. Diluted earning per share from operating results were $0.85 for the 2015 period and $0.87 for the comparable 2014 period. Total diluted shares were 12.4 million for the 2015 First Six Months and 12.2 million for the 2014 First Six Months.
Net Patient Revenues
- Net patient revenues increased to $157.3 million for the 2015 First Six Months from $144.9 million for the 2014 First Six Months, an increase of $12.4 million due to an increase in visits of 66,700 from New Clinics and an increase in visits of 60,400 from Mature Clinics offset by a decrease in the average net revenue per visit in for the current period of $0.75 from $106.31 for the 2014 period to $105.56 for the 2015 period.
- Net patient revenues related to New Clinics amounted to $7.1 million for the 2015 First Six Months and net patient revenues for Mature Clinics increased by $5.3 million for the 2015 First Six Months as compared to the 2014 First Six Month primarily due to the April 2014 Acquisition having a full six months of revenue in 2015 and only two months in 2014.
Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers’ compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under these programs are based on predetermined rates and are generally less than the established billing rates.
Other Revenues
Other revenues increased $0.2 million in the 2015 First Six Months to $3.3 million from $3.1 million in the 2014 First Six Months.
Clinic Operating Costs
Clinic operating costs as a percentage of net revenues were $122.5 million, or 76.3% of net revenues, for the 2015 First Six Months and $109.5 million, or 74.0% of net revenues, for the 2014 First Six Months. The increase was primarily attributable to $6.4 million in operating costs of New Clinics and an increase in operating costs of $6.6 million for Mature Clinics primarily due to the April 2014 Acquisition having a full six months of expenses in 2015 and only two months in 2014. Each component of clinic operating costs is discussed below:
Clinic Operating Costs—Salaries and Related Costs
Salaries and related costs increased to $87.5 million for the 2015 First Six Months from $78.1 million for the 2014 First Six Months, an increase of $9.4 million. Salaries and related costs for New Clinics amounted to $4.5 million for the 2015 First Six Months. Salaries and related costs for Mature Clinics increased by $4.9 million for the 2015 First Six Months as compared to the 2014 First Six Months. Salaries and related costs as a percentage of net revenues were 54.5% for the 2015 First Six Months and 52.7% for the 2014 First Six Months.
Clinic Operating Costs—Rent, Clinic Supplies, Contract Labor and Other
Rent, clinic supplies, contract labor and other were $33.0 million for the 2015 First Six Months and $29.4 million for the 2014 First Six Months. For New Clinics, rent, clinic supplies, contract labor and other amounted to $1.8 million for the 2015 First Six Months. For Mature Clinics, rent, clinic supplies, contract labor and other increased by $1.8 million in the 2015 First Six Months compared to the 2014 First Six Months. Rent, clinic supplies, contract labor and other as a percentage of net revenues was 20.6% for the 2015 First Six Months and 19.9% for the 2014 First Six Months.
Clinic Operating Costs—Provision for Doubtful Accounts
The provision for doubtful accounts was $2.1 million for the 2015 First Six Months and $2.0 million for the 2014 First Six Months. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 1.3% for the 2015 First Six Months and 1.4% for the 2014 First Six Months.
Our allowance for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 4.4% at June 30, 2015, as compared to 4.8% at December 31, 2014. Our days sales outstanding was 38 days at June 30, 2015 and 39 days at December 31, 2014.
Corporate Office Costs
Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, accounting, professional, and recruiting fees, were $15.3 million for the 2015 First Six Months and $14.8 million for the 2014 First Six Months. The increase was primarily due to an increase in the number of employees and related compensation and benefits and an increase in equity-based awards compensation expense. As a percentage of net revenues, corporate office costs were 9.5% for the 2015 First Six Months and 10% for 2014 First Six Months.
Interest Expense
Interest expense decreased to $510,000 in the 2015 First Six Months compared to $585,000 in the 2014 First Six Months due to a lower average outstanding balance under our revolving credit agreement during the 2015 period compared to the 2014 period. At June 30, 2015, $41.0 million was outstanding under our revolving credit agreement.
Provision for Income Taxes
The provision for income taxes was $7.0 million for the 2015 First Six Months and $7.4 million for the 2014 First Six Months. During the 2015 and 2014 First Six Months, we accrued state and federal income taxes at an effective tax rate (provision for taxes divided by the difference between income before taxes and net income attributable to non-controlling interests) of 40.0% and 41%, respectively.
Non-controlling Interests
Net income attributable to non-controlling interests was $4.8 million for the 2015 First Six Months and $5.1 million for the 2014 First Six Months or as a percentage of operating income before corporate office costs was 12.6% for the 2015 First Six Months and 13.2% for the 2014 First Six Months.
LIQUIDITY AND CAPITAL RESOURCES
We believe that our business is generating sufficient cash flow from operations to allow us to meet our short-term and long-term cash requirements, other than those with respect to future acquisitions. At June 30, 2015 and December 31, 2014, we had $13.0 million and $14.3 million, respectively, in cash. Although the start-up costs associated with opening new clinics and our planned capital expenditures are significant, we believe that our cash and unused availability under our revolving credit agreement are sufficient to fund the working capital needs of our operating subsidiaries, future clinic development and acquisitions and investments through at least March 2016. The amount outstanding under our revolving credit facility was $41.0 million at June 30, 2015 compared to $34.5 million at December 31, 2014. At June 30, 2015 we had $84.0 million available under our revolving credit facility. Significant acquisitions would likely require financing under our revolving credit facility.
During the six months ended June 30, 2015, $19.2 million was provided by operations and $6.5 million was drawn on our revolving credit agreement. The major uses of cash included: purchases of businesses ($14.5 million), distributions to non-controlling interest partners ($4.9 million), payments of cash dividends to our shareholders ($3.7 million), purchases of fixed assets ($2.9 million), purchases of non-controlling interests ($1.0 million) and payments on our notes payable ($0.6 million).
Effective December 5, 2013, we entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility with a maturity date of November 30, 2018 (“Credit Agreement”). The Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Credit Agreement may be used for working capital, acquisitions, purchases of our common stock, dividend payments to our common shareholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.5% to 2.3% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Credit Agreement include an unused commitment fee ranging from 0.1% to 0.25% depending on our consolidated leverage ratio and the amount of funds outstanding under the Credit Agreement. On June 30, 2015, $41.0 million was outstanding on the revolving credit facility resulting in $84.0 million of availability, and we were in compliance with all of the covenants thereunder.
On June 30, 2015, we acquired a 70% interest in a four-clinic physical therapy practice. The purchase price was $3.6 million in cash and $0.7 million in seller notes that are payable plus accrued interest, in June 2018. On April 30, 2015, we acquired a 70% interest in a three-clinic physical therapy practice. The purchase price was $4.75 million in cash and $0.15 million in a seller note that is payable in two principal installments of $75,000 each, plus accrued interest, in April 2016 and 2017. On January 31, 2015, we acquired a 60% interest in a nine-clinic physical therapy practice. The purchase price for the 60% interest was $6.7 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in January 2016 and 2017.
Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing new clinics and making additional acquisitions. We also from time to time purchase the non-controlling interests in our Clinic Partnerships. Generally, any acquisition or purchase of non-controlling interests is expected to be accomplished using a combination of cash and financing. Significant acquisitions would likely require financing under our revolving credit facility.
We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts, in a consistent manner for all payor types. Claims are submitted to payors daily, weekly or monthly in accordance with our policy or payor’s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose payment of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting Medicare Rehab Agency status approval initially may not be submitted for six months or more. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial health plans and self-pay payor type receivables, the write-off generally occurs after the account receivable has been outstanding for at least 120 days.
We generally enter into various notes payable as a means of financing our acquisitions. Our present outstanding notes payable relate to certain of the acquisitions of businesses and a purchase of non-controlling interest that occurred in 2013 through 2015. For those acquisitions, we entered into several notes payables aggregating $3.1 million. Generally, the notes are payable in equal annual installments of principal over two years plus any accrued and unpaid interest. Interest accrues at various interest rates ranging from 3.25% to 4.0% per annum, subject to adjustment. In addition, we assumed leases with remaining terms of 1 month to 6 years for the operating facilities. At June 30, 2015, the balance on these notes payable was $1.9 million.
In conjunction with the above mentioned acquisitions, in the event that a limited minority partner’s employment ceases at any time after three years from the acquisition date, we have agreed to repurchase that individual’s non-controlling interest at a predetermined multiple of earnings before interest and taxes.
As of June 30, 2015, we have accrued $1.9 million related to credit balances and overpayments due to patients and payors. This amount is expected to be paid in 2015. Of this $1.9 million, $710,000 relates to a limited partnership in which we own a majority interest, which is in the process of resolving an investigation by the U.S. Department of Justice into certain Medicare billings that occurred between 2007 and 2009 at a single outpatient physical therapy clinic. It is expected that a settlement agreement will be entered into which will conclude the government’s review into whether certain physical therapy services provided to a limited number of Medicare patients at the clinic satisfied all of the criteria for payment by the Medicare program. The issue at the clinic related to a Medicare regulation, unique to a private practice setting, that requires a different level of supervision for a claim to qualify for payment when the services are performed by a licensed physical therapist assistant. The Medicare supervision requirements go beyond what is required under the state licensing law, the physical therapist assistant scope of practice, and professional standards of care. The limited partnership has tentatively agreed to pay $710,000 to resolve the matter. The settlement expense was estimated and accrued for in 2012. We, along with the limited partnership, have cooperated fully in the government review and the Company conducted its own internal audit of all of the Medicare claims submitted by that clinic during the relevant period in order to assist the government in determining the appropriate dollar amount that should be refunded. As is customary at the conclusion of such government investigations, it is anticipated that the limited partnership and the Company will enter into a Corporate Integrity Agreement (CIA) that will be incorporated into the Company’s existing comprehensive compliance program.
From September 2001 through December 31, 2008, our Board of Directors (“Board”) authorized us to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of our common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (“March 2009 Authorization”). In connection with the March 2009 Authorization, we amended our bank credit agreement to permit share repurchases of up to $15,000,000. We are required to retire shares purchased under the March 2009 Authorization. Effective October 24, 2012, we amended the Credit Agreement to permit us to purchase, commencing on October 24, 2012 and at all times thereafter, up to $15,000,000 of our common stock subject to compliance with covenants.
There is no expiration date for the share repurchase program. As of June 30, 2015, there are currently an additional estimated 273,900 shares (based on the closing price of $54.76 on June 30, 2015) that may be purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase any shares of our common stock during the six months ended June 30, 2015.
FACTORS AFFECTING FUTURE RESULTS
The risks related to our business and operations include:
- changes as the result of government enacted national healthcare reform;
- changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
- business and regulatory conditions including federal and state regulations;
- governmental and other third party payor investigations and audits;
- compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply;
- changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
- transition to ICD - 10 coding system;
- revenue and earnings expectations;
- general economic conditions;
- availability and cost of qualified physical therapists;
- personnel productivity;
- competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
- acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
- maintaining adequate internal controls;
- availability, terms, and use of capital; and
- weather and other seasonal factors.
See Risk Factors in Item 1A of our Annual Report on Form 10-K.
Forward-Looking Statements
We make statements in this report that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934, as (the “Exchange Act”). These statements contain forward-looking information relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:
- changes as the result of government enacted national healthcare reform;
- changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
- business and regulatory conditions including federal and state regulations;
- governmental and other third party payor investigations and audits;
- compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply;
- changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
- transition to ICD - 10 coding system;
- revenue and earnings expectations;
- general economic conditions;
- availability and cost of qualified physical and occupational therapists;
- personnel productivity;
- competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
- acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
- maintaining adequate internal controls;
- availability, terms, and use of capital; and
- weather and other seasonal factors.
Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission (the “SEC”) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer accurate.
Market risk
As filed, 549 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We do not maintain any derivative instruments, interest rate swap arrangements, hedging contracts, futures contracts or the like. Our primary market risk exposure is the changes in interest rates obtainable on our Credit Agreement. The interest on our Credit Agreement is based on a variable rate. At June 30, 2015, $41.0 million was outstanding under our Credit Agreement. Based on the balance of the Credit Agreement at June 30, 2015, any change in the interest rate of 1% would yield a decrease or increase in annual interest expense of $410,000.
Controls and procedures
As filed, 1,386 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, the Company’s management completed an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our principal executive officer and principal financial officer concluded (i) that our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and (ii) that our disclosure controls and procedures are effective.
(b) Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $83.3m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $160.5m | us-gaap:SalesRevenueNet |
| Gross profit | 3 months2015-04-01 to 2015-06-30 | $21.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2015-01-01 to 2015-06-30 | $38.0m | us-gaap:GrossProfit |
| Operating income | 3 months2015-04-01 to 2015-06-30 | $13.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-01-01 to 2015-06-30 | $22.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $245.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $510.0k | us-gaap:InterestExpense |
| Income tax | 3 months2015-04-01 to 2015-06-30 | $4.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2015-01-01 to 2015-06-30 | $7.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-04-01 to 2015-06-30 | $6.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-01-01 to 2015-06-30 | $10.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | $0.48 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2015-01-01 to 2015-06-30 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | $0.48 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-01-01 to 2015-06-30 | $0.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 12,409,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-01-01 to 2015-06-30 | 12,362,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | $19.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2015-01-01 to 2015-06-30 | $2.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2015-01-01 to 2015-06-30 | $3.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2015-06-30 | $13.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $55.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $268.3m | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $21.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $75.7m | us-gaap:Liabilities |
| Long-term debt | At period end2015-06-30 | $42.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-06-30 | $800.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-06-30 | $155.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001140361-15-030102. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.